EQUITA advised Alfatest


Alfatest, along with its subsidiary AlfatestLab, one of Italy's most respected companies in analytical instrumentation and laboratory science, was acquired by Oxevia, a European group dedicated to bringing essential scientific solutions to research and industry.
The partnership is aligned with Oxevia’s strategy of building a focused group of specialised companies within analytical and diagnostic solutions. Oxevia connects niche leaders across instruments, consumables, and services to create a stronger and more complete partner for research, clinical and industrial applications.
Alfatest will continue to operate under its established brand, with its current organisation and leadership remaining in place.
Alfatest and AlfatestLab were advised as financial advisor by the Mid Cap Advisory team of EQUITA, the Italian partner of Clairfield International, by the law firm Pavia e Ansaldo on legal matters and by Studio Colamarco Nicola on tax matters. Oxevia was advised by Giovannelli e Associati Law Firm on legal matters and by Grant Thornton on accounting and tax matters.
Valentino Polchi, CEO of Alfatest, says: “Joining Oxevia is a natural next step for Alfatest. We have always believed that expertise, innovation and support are what distinguish us and that will not change. What changes is that we now have a long-term partner beside us who shares our ambition for this industry. Our customers and partners can expect the same dedication from our team, with even greater capacity to invest in the future.”
Sasha Hakami, co-founder of Oxevia, adds: “We are proud of teaming up with Alfatest, a highly specialised company with a strong position in the Italian market and deep application knowledge. Oxevia is built to bring together companies like Alfatest into a broader ecosystem, where each company keeps its identity while gaining access to shared capabilities, expertise, and market reach.”
